GR3026638T3 - 5-Methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4T). - Google Patents

5-Methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4T).

Info

Publication number
GR3026638T3
GR3026638T3 GR980400839T GR980400839T GR3026638T3 GR 3026638 T3 GR3026638 T3 GR 3026638T3 GR 980400839 T GR980400839 T GR 980400839T GR 980400839 T GR980400839 T GR 980400839T GR 3026638 T3 GR3026638 T3 GR 3026638T3
Authority
GR
Greece
Prior art keywords
methyluridine
didehydro
deoxythymidine
scale preparation
alpha
Prior art date
Application number
GR980400839T
Other languages
English (en)
Inventor
Bang-Chi Chen
Derron R Stark
Stephen R Baker
Sandra L Quinlan
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of GR3026638T3 publication Critical patent/GR3026638T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR980400839T 1993-11-15 1998-04-14 5-Methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4T). GR3026638T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15277893A 1993-11-15 1993-11-15
US15305893A 1993-11-15 1993-11-15
US08/309,637 US5672698A (en) 1993-11-15 1994-09-23 Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine

Publications (1)

Publication Number Publication Date
GR3026638T3 true GR3026638T3 (en) 1998-07-31

Family

ID=27387314

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400839T GR3026638T3 (en) 1993-11-15 1998-04-14 5-Methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4T).

Country Status (17)

Country Link
US (1) US5672698A (el)
EP (1) EP0653436B1 (el)
JP (2) JP3653292B2 (el)
KR (1) KR100329525B1 (el)
CN (2) CN1040115C (el)
AT (1) ATE162530T1 (el)
AU (1) AU686672B2 (el)
CA (1) CA2135852C (el)
DE (1) DE69408099T2 (el)
DK (1) DK0653436T3 (el)
ES (1) ES2113626T3 (el)
FI (1) FI115971B (el)
GR (1) GR3026638T3 (el)
HU (2) HU222118B1 (el)
IL (1) IL111569A (el)
SG (1) SG63554A1 (el)
TW (1) TW291480B (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5608049A (en) * 1995-03-10 1997-03-04 Bristol-Myers Squibb Company Preparation of d4T from 5-methyluridine
US5608048A (en) * 1995-06-05 1997-03-04 Bristol-Myers Squibb Company d4 T polymorphic Form 1 process
US7034009B2 (en) * 1995-10-26 2006-04-25 Sirna Therapeutics, Inc. Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
US6482805B2 (en) 1998-03-25 2002-11-19 Parker Hughes Institute AZT derivatives exhibiting spermicidal and anti-viral activity
US6191120B1 (en) 1998-03-25 2001-02-20 Wayne Hughes Institute Spermicidally active 5-halo-6-alkoxy-5,6-dihydro-2′,3′-dideoxy-uridines and their pharamaceutical compositions
WO2002038576A1 (en) * 2000-11-13 2002-05-16 Parker Hughes Institute ARYL PHOSPHATE DERIVATIVES OF d4T
US7144874B2 (en) * 2002-10-25 2006-12-05 Parker Hughes Institute Aryl phosphate derivatives of d4T having activity against resistant HIV strains
US6030957A (en) * 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity
US20070015733A1 (en) * 1998-06-29 2007-01-18 Parker Hughes Institute Aryl Phosphate Derivatives of d4T having Activity Against Resistant HIV Strains
CN1055293C (zh) * 1998-10-06 2000-08-09 中国人民解放军第二军医大学 一种β-胸苷的制备方法
AU2001285197A1 (en) * 2000-09-06 2002-03-22 Bristol-Myers Squibb Company Stavudine polymorphic form 1 process
US6825177B2 (en) * 2000-10-30 2004-11-30 Parker Hughes Institute Aryl phosphate derivatives of d4T with potent anti-viral activity
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
WO2006026656A1 (en) * 2004-08-31 2006-03-09 Parker Hughes Institute Cytotoxic nucleoside analog compound 003 for treating cancer
CN102180925B (zh) * 2011-03-22 2013-05-08 苏州迪马生物科技发展有限公司 5-甲基尿苷合成工艺中乳化层的处理方法
CN104926902A (zh) * 2014-03-17 2015-09-23 张容霞 2`-取代-2,2`-脱水尿苷或2`-取代-2,2`-脱水胞苷化合物及其制备方法和用途
CN106967767B (zh) * 2017-04-25 2019-09-24 苏州笃美生物科技有限公司 一种β-胸苷的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU110888A (en) * 1987-06-10 1989-08-31 Wellcome Found Process for obtaining timine derivatives
US4921950A (en) * 1988-06-09 1990-05-01 Burroughs Wellcome Co. Preparation of 3'azido-3-'-deoxythymidine
JP3128080B2 (ja) * 1991-10-02 2001-01-29 日本製紙株式会社 核酸化合物の新規な製造方法

Also Published As

Publication number Publication date
SG63554A1 (en) 1999-03-30
FI945323A0 (fi) 1994-11-11
EP0653436B1 (en) 1998-01-21
HU0105348D0 (en) 2002-02-28
DK0653436T3 (da) 1998-09-14
KR100329525B1 (ko) 2002-11-14
TW291480B (el) 1996-11-21
CN1040115C (zh) 1998-10-07
CN1055477C (zh) 2000-08-16
CN1193021A (zh) 1998-09-16
FI945323A (fi) 1995-05-16
IL111569A0 (en) 1995-01-24
DE69408099T2 (de) 1998-09-03
JPH07206856A (ja) 1995-08-08
HU9403257D0 (en) 1995-01-30
JP3653292B2 (ja) 2005-05-25
AU686672B2 (en) 1998-02-12
ES2113626T3 (es) 1998-05-01
EP0653436A1 (en) 1995-05-17
CN1112123A (zh) 1995-11-22
CA2135852C (en) 2006-01-03
KR950014132A (ko) 1995-06-15
DE69408099D1 (de) 1998-02-26
JP2005139197A (ja) 2005-06-02
HUT69172A (en) 1995-08-28
CA2135852A1 (en) 1995-05-16
FI115971B (fi) 2005-08-31
HU222119B1 (hu) 2003-04-28
AU7880494A (en) 1995-06-01
ATE162530T1 (de) 1998-02-15
HU222118B1 (hu) 2003-04-28
US5672698A (en) 1997-09-30
IL111569A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
TW291480B (el)
EP0285884A3 (en) process to produce 2', 3'-dideoxynucleosides
KR0140889B1 (en) Production of 2',3'-dideoxy-2',3'-didehydronucleosides
CA2088363A1 (en) Process for the preparation of nucleotides
CY2046B1 (en) Process for large scale preparation of 2',3'-didehydro-2',3'-dideonucleosides
YU64494A (sh) Asimterična sinteza (s)-(-)-6-hlor-4-ciklopropil-3,4-dihidro-4-/(2-piridil)etinil/-2(1h)-hinazolinona
HUP9601517A2 (en) Process for producing polymorphic form i of d4t (2',3'-didehydro-3'-deoxy-timidine)
FR2701027B1 (fr) Procede de synthese ameliore du 9-(beta-d-arabinofuranosyl)adenine 5'-phosphate.
IL110968A0 (en) Nucleosides, nucleotides and oligonucleotides comprising tris-4,4',4"-tert-butylphenylmethyl, as protected group and their preparation
ES2026059A6 (es) Procedimiento mejorado para la sintesis de 1-((1-(2-(trifluoreometil)-4-pirimidinil)-4-piperidinil)metil)-2-pirrolidinona.
AU630007B2 (en) Process for producing des(64,65)-proinsulin
IL131513A0 (en) Method for producing 1,3-di-substituted 2-nitroguanidines
AU1327788A (en) Process to produce 2',3'-dideoxynucleosides
MX9706883A (es) Procedimiento para preparar prostaglandinas e1 y e2 y analogos de las mismas usando reactivos de furilo-cobre.
UA10114A (uk) СПОСІБ ОДЕРЖАННЯ 1-beta-D-АРАБІНОФУРАНОЗИДУ ЦИТОЗИНА
HU9501132D0 (en) Process for producing of 6-methoxy-1-oxo-1,2,3,4-tetrahydronaphtalene
IL105572A0 (en) Production of 2',3'-dideoxy-2',3'-didehydronucleosides
IL105571A0 (en) Production of 2',3'-dideoxy-2',3'-didehydronucleosides
IL105570A0 (en) Production of 2',3'-dideoxy-2',3'-didehydronucleosides